Last 19,700 KRW
Change Today +400.00 / 2.07%
Volume 53.0K
102460 On Other Exchanges
Symbol
Exchange
Korea SE
As of 2:05 AM 04/18/14 All times are local (Market data is delayed by at least 15 minutes).

reyon pharmaceutical co ltd (102460) Snapshot

Open
19,250
Previous Close
19,300
Day High
19,750
Day Low
19,250
52 Week High
04/25/13 - 26,700
52 Week Low
06/25/13 - 15,750
Market Cap
254.1B
Average Volume 10 Days
64.1K
EPS TTM
875.00
Shares Outstanding
12.9M
EX-Date
12/27/13
P/E TM
22.5x
Dividend
150.00
Dividend Yield
0.76%
Current Stock Chart for REYON PHARMACEUTICAL CO LTD (102460)

Related News

No related news articles were found.

reyon pharmaceutical co ltd (102460) Related Businessweek News

No Related Businessweek News Found

reyon pharmaceutical co ltd (102460) Details

REYON Pharmaceutical Co., Ltd. engages in the manufacture and sale of finished medicines and active pharmaceutical ingredients in South Korea and internationally. The company offers various products, such as injections, eye drops, antibiotics, coagulation drugs, skeletal muscle relaxants, anti-inflammatory enzymes, local anesthics, blood vessel dialectic drugs, anti cancer drugs, cardiac strengthening drugs, and anti-inflammatory pain reliever. Its pharmaceutical products include carvedil, mepril, finascar, seronase, opti-v eye drop, mitron, enoron, teiconin, akocin, and vecaron. The company distributes its products to customers through hospitals, clinics, pharmacies, retail stores, and overseas pharmaceutical companies. REYON Pharmaceutical Co., Ltd. was founded in 1955 and is based in Seoul, South Korea.

Founded in 1955

reyon pharmaceutical co ltd (102460) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

reyon pharmaceutical co ltd (102460) Key Developments

REYON Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Jan 17, 2014

REYON Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Jan 17, 2014., at 10:00 Korea Standard Time. Location: 3rd floor, 26 to go 6 clear room. Agenda: To consider the audit report; to consider the some change in constitution; and to consider the appointment of two internal directors.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
102460:KS 19,700.00 KRW +400.00

102460 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 102460.
View Industry Companies
 

Industry Analysis

102460

Industry Average

Valuation 102460 Industry Range
Price/Earnings 22.9x
Price/Sales 2.4x
Price/Book 1.8x
Price/Cash Flow 22.7x
TEV/Sales 1.8x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REYON PHARMACEUTICAL CO LTD, please visit www.reyonpharm.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.